
Apyx Medical Corporation
APYXNASDAQHealthcareMedical - Specialties
Previous close
$3.12
+$0.09 · +2.97%
APYX company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
75
Undervalued
Momentum
53
Neutral
Sentiment
49
Mixed
Risk resilience
43
Elevated Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteApyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company’s helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
- Industry
- Medical - Specialties
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Charles D. Goodwin
- Listed since
- Jan 2, 2019
- Employees
- 205
Market position
Day range
Current $3.12
52-week range
Current $3.12
- Open
- $3.06
- Previous close
- $3.03
- Volume
- 52.89K
- 0.35× average
- Average volume
- 149.59K
- Average daily volume
- Market cap
- 131.38M USD
- Beta
- 1.35
- Market reference 1
- 50-day average
- $4.0034
- -22.07% below average
- 200-day average
- $3.8512
- -18.99% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- P/E (TTM)
- -15.09×
- P/B (TTM)
- 12.34×
- P/S (TTM)
- 2.25×
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 33.94%
- Operating margin
- -6.06%
- Net margin
- -14.78%
Financial health
- Debt / equity
- 3.72×
- Altman Z-score
- 1.1
- Piotroski F-score
- 3 of 9
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Rating distribution
9 ratingsAPYX peers
ETFs holding APYX
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 4.49M
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
Vanguard Extended Market ETFVXF- Market value
- 1.64M
- Weight
- 0.00%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
iShares Micro-Cap ETFIWC- Market value
- 385.99K
- Weight
- 0.03%
- AUM
- 1.53B USD
- Expense ratio
- 0.60%
- Price / 1D
- $198.39+1.10%
Dimensional - US Core Equity 2 ETFDFAC- Market value
- 2.22K
- Weight
- 0.00%
- AUM
- 49.31B USD
- Expense ratio
- 0.17%
- Price / 1D
- $45.61+0.46%
Continue in GoAI
Research APYXresearch.disclaimer





